NCT06534853 Comparison of Post Facilitation Stretch Versus Reciprocal Inhibition in Quadratus Lumborum Syndrome: a Randomized Controlled Trial
| NCT ID | NCT06534853 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Quadratus Lumborum Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2023-09-01 with a primary completion date of 2025-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to determine the effects Post facilitation stretch versus reciprocal inhibition on pain, lumbar range of motion, apparent leg length discrepancy and lumbar lordotic angle in Quadratus Lumborum Syndrome.
Eligibility Criteria
Inclusion Criteria: * Age 18-35 years * Both genders * Having pain of ≤ 8 on NPRS from at least 3 months * Pain decreases on supine lying * Any two of the following findings positive of unilateral quadratus lumborum on physical examination: 1. Taut bands 2. Local tenderness 3. Patient's pain recognition 4. Pain referral to greater trochanter 5. Local twitch response Exclusion criteria: * Painful isometric muscle testing of hip flexors, abductors, adductors, and extensors * Previous surgery of lower limb * Centralization/peripheralization * Lower back trauma * Positive SLR * Radiculopathy * Fracture/surgery of pelvic and/or hip region * Diagnosed fibromyalgia or other rheumatic diseases. * Lactating women * Intrauterine device * Pregnant women * Use of psychiatric medications
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06534853 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Quadratus Lumborum Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06534853 currently recruiting?
Yes, NCT06534853 is actively recruiting participants. Contact the research team at aqsaayaz77@gmail.com for enrollment information.
Where is the NCT06534853 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT06534853 clinical trial?
NCT06534853 is sponsored by Foundation University Islamabad. The trial plans to enroll 42 participants.